Table 2.
Parameters | VAS | PASS20 | BDI-II | Lequesne | |||||
---|---|---|---|---|---|---|---|---|---|
r | p | r | p | r | p | r | p | ||
Age | 0.17 | 0.35 | 0.46 | 0.009* | 0.13 | 0.49 | 0.2 | 0.27 | |
BMI | 0.53 | 0.002* | 0.04 | 0.84 | 0.29 | 0.11 | 0.38 | 0.03* | |
Disease duration | 0.04 | 0.84 | 0.16 | 0.37 | 0.09 | 0.64 | 0.2 | 0.26 | |
VAS | —– | —– | 0.48 | 0.006* | 0.53 | 0.002* | 0.64 | <0.001* | |
PSQI | 0.23 | 0.21 | 0.4 | 0.02* | 0.18 | 0.32 | 0.28 | 0.11 | |
PASS20 | 0.48 | 0.006* | —– | —– | 0.25 | 0.16 | 0.37 | 0.04* | |
BDI-II | 0.53 | 0.002* | 0.25 | 0.16 | —– | —– | 0.17 | 0.37 | |
Lequesne’s score | 0.64 | <0.001* | 0.37 | 0.04* | 0.17 | 0.37 | —– | —– | |
FIQ | 0.56 | <0.001* | 0.77 | <0.001* | 0.32 | 0.07 | 0.47 | 0.006* | |
Quality of life | Physical | −0.62 | <0.001* | −0.71 | <0.001* | −0.4 | 0.02* | −0.42 | 0.02* |
Cognitive | −0.1 | 0.57 | −0.47 | 0.007* | 0.1 | 0.6 | −0.09 | 0.6 | |
Affective | −0.36 | 0.046* | −0.67 | <0.001* | −0.1 | 0.6 | −0.32 | 0.08 | |
Social | −0.39 | 0.026* | −0.7 | <0.001* | −0.35 | 0.049* | −0.29 | 0.1 | |
Economic | 0.12 | 0.52 | −0.11 | 0.56 | −0.03 | 0.87 | −0.04 | 0.85 | |
Ego | −0.03 | 0.88 | −0.5 | 0.004* | 0.13 | 0.49 | −0.04 | 0.85 |
Note: *p<0.05.
Abbreviations: KOA, knee osteoarthritis; FM, fibromyalgia; BMI, body mass index; VAS, visual analog scale; PSQI, Pittsburgh Sleep Quality Index; PASS20, Pain Anxiety Symptom Scale Short Form 20; BDI-II, Beck Depression Inventory; FIQ, Fibromyalgia Impact Questionnaire.